{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,15]],"date-time":"2026-02-15T14:41:58Z","timestamp":1771166518503,"version":"3.50.1"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"Health and Medical Research Fund of Hong Kong","award":["HMRF14130962"],"award-info":[{"award-number":["HMRF14130962"]}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["HHSN272201400006C"],"award-info":[{"award-number":["HHSN272201400006C"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Research Grant Council of Hong Kong","award":["T11-705\/14N"],"award-info":[{"award-number":["T11-705\/14N"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Virology"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.virol.2018.09.007","type":"journal-article","created":{"date-parts":[[2018,9,21]],"date-time":"2018-09-21T20:30:19Z","timestamp":1537561819000},"page":"73-82","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Combined use of live-attenuated and inactivated influenza vaccines to enhance heterosubtypic protection"],"prefix":"10.1016","volume":"525","author":[{"given":"Li-Meng","family":"Yan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olive T.W.","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chek M.","family":"Poh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ranawaka A.P.M.","family":"Perera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sophie A.","family":"Valkenburg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Malik","family":"Peiris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leo L.M.","family":"Poon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"23","key":"10.1016\/j.virol.2018.09.007_bib1","doi-asserted-by":"crossref","first-page":"12388","DOI":"10.1128\/JVI.76.23.12388-12393.2002","article-title":"Compromised influenza virus-specific CD8(+)-T-cell memory in CD4(+)-T-cell-deficient mice","volume":"76","author":"Belz","year":"2002","journal-title":"J. Virol."},{"issue":"2","key":"10.1016\/j.virol.2018.09.007_bib2","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.virol.2005.06.006","article-title":"Immunization against influenza A virus: comparison of conventional inactivated, live-attenuated and recombinant baculovirus produced purified hemagglutinin and neuraminidase vaccines in a murine model system","volume":"339","author":"Brett","year":"2005","journal-title":"Virology"},{"key":"10.1016\/j.virol.2018.09.007_bib3","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2016.00427","article-title":"Modulation of primary immune response by different vaccine adjuvants","volume":"7","author":"Ciabattini","year":"2016","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.virol.2018.09.007_bib4","doi-asserted-by":"crossref","first-page":"73","DOI":"10.4103\/0974-777X.77299","article-title":"Fundamentals of vaccine immunology","volume":"3","author":"Clem","year":"2011","journal-title":"J. Glob. Infect. Dis."},{"issue":"2","key":"10.1016\/j.virol.2018.09.007_bib5","doi-asserted-by":"crossref","DOI":"10.3390\/vaccines3020293","article-title":"Measuring cellular immunity to influenza: methods of detection, applications and challenges","volume":"3","author":"Coughlan","year":"2015","journal-title":"Vaccines"},{"issue":"2","key":"10.1016\/j.virol.2018.09.007_bib6","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/nm.3443","article-title":"Broadly neutralizing hemagglutinin stalk\u2013specific antibodies require Fc\u03b3R interactions for protection against influenza virus in vivo","volume":"20","author":"DiLillo","year":"2014","journal-title":"Nat. Med."},{"issue":"2","key":"10.1016\/j.virol.2018.09.007_bib7","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.coviro.2012.02.005","article-title":"Broadly neutralizing antibodies against influenza virus and prospects for universal therapies","volume":"2","author":"Ekiert","year":"2012","journal-title":"Curr. Opin. Virol."},{"issue":"8","key":"10.1016\/j.virol.2018.09.007_bib8","doi-asserted-by":"crossref","first-page":"796","DOI":"10.3201\/eid0805.010476","article-title":"DNA vaccine expressing conserved influenza virus proteins protective against H5N1 challenge infection in mice","volume":"8","author":"Epstein","year":"2002","journal-title":"Emerg. Infect. Dis."},{"issue":"46","key":"10.1016\/j.virol.2018.09.007_bib9","doi-asserted-by":"crossref","first-page":"5404","DOI":"10.1016\/j.vaccine.2005.04.047","article-title":"Protection against multiple influenza A subtypes by vaccination with highly conserved nucleoprotein","volume":"23","author":"Epstein","year":"2005","journal-title":"Vaccine"},{"issue":"21","key":"10.1016\/j.virol.2018.09.007_bib10","doi-asserted-by":"crossref","first-page":"10762","DOI":"10.1128\/JVI.01443-15","article-title":"Generation of live attenuated influenza virus by using codon usage bias","volume":"89","author":"Fan","year":"2015","journal-title":"J. Virol."},{"issue":"5","key":"10.1016\/j.virol.2018.09.007_bib11","doi-asserted-by":"crossref","first-page":"2814","DOI":"10.1128\/JVI.79.5.2814-2822.2005","article-title":"Characterization of a novel influenza A virus hemagglutinin subtype (H16) obtained from black-headed gulls","volume":"79","author":"Fouchier","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2018.09.007_bib12","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.coviro.2016.01.016","article-title":"Human influenza viruses and CD8+T cell responses","volume":"16","author":"Grant","year":"2016","journal-title":"Curr. Opin. Virol."},{"issue":"9","key":"10.1016\/j.virol.2018.09.007_bib13","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/j.micinf.2008.07.002","article-title":"Heterosubtypic immunity to influenza A virus: where do we stand?","volume":"10","author":"Grebe","year":"2008","journal-title":"Microbes Infect."},{"issue":"5","key":"10.1016\/j.virol.2018.09.007_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr6505a1","article-title":"Prevention and control of seasonal influenza with vaccines","volume":"65","author":"Grohskopf","year":"2016","journal-title":"MMWR Recomm. Rep."},{"issue":"8","key":"10.1016\/j.virol.2018.09.007_bib15","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1016\/j.vaccine.2017.01.018","article-title":"Improving the selection and development of influenza vaccine viruses - report of a WHO informal consultation on improving influenza vaccine virus selection, Hong Kong SAR, China, 18-20 November 2015","volume":"35","author":"Hampson","year":"2017","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.virol.2018.09.007_bib16","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jim.2007.03.002","article-title":"Optimization and validation of an 8-color intracellular cytokine staining (ICS) assay to quantify antigen-specific T cells induced by vaccination","volume":"323","author":"Horton","year":"2007","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.virol.2018.09.007_bib17","series-title":"WHO Manual on Animal Influenza Diagnosis and Surveillance","author":"Infl","year":"2002"},{"issue":"4","key":"10.1016\/j.virol.2018.09.007_bib18","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.4049\/jimmunol.1201574","article-title":"Cross-reactive influenza-specific antibody-dependent cellular cytotoxicity antibodies in the absence of neutralizing antibodies","volume":"190","author":"Jegaskanda","year":"2013","journal-title":"J. Immunol."},{"issue":"5","key":"10.1016\/j.virol.2018.09.007_bib19","doi-asserted-by":"crossref","first-page":"e1004134","DOI":"10.1371\/journal.ppat.1004134","article-title":"Suppressor of cytokine signaling 4 (SOCS4) protects against severe cytokine storm and enhances viral clearance during influenza infection","volume":"10","author":"Kedzierski","year":"2014","journal-title":"PLoS Pathog."},{"issue":"23","key":"10.1016\/j.virol.2018.09.007_bib20","doi-asserted-by":"crossref","first-page":"9047","DOI":"10.1073\/pnas.1118979109","article-title":"Pandemic H1N1 influenza vaccine induces a recall response in humans that favors broadly cross-reactive memory B cells","volume":"109","author":"Li","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"19","key":"10.1016\/j.virol.2018.09.007_bib21","doi-asserted-by":"crossref","first-page":"10435","DOI":"10.1128\/JVI.01715-13","article-title":"Hemagglutinin stalk-based universal vaccine constructs protect against group 2 influenza A viruses","volume":"87","author":"Margine","year":"2013","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2018.09.007_bib22","series-title":"Seminars in Immunology","article-title":"Functions of CD8 T-cell subsets secreting different cytokine patterns","author":"Mosmann","year":"1997"},{"issue":"22","key":"10.1016\/j.virol.2018.09.007_bib23","doi-asserted-by":"crossref","first-page":"13260","DOI":"10.1128\/JVI.02133-14","article-title":"Induction of broadly reactive anti-hemagglutinin stalk antibodies by an H5N1 vaccine in humans","volume":"88","author":"Nachbagauer","year":"2014","journal-title":"J. Virol."},{"issue":"1","key":"10.1016\/j.virol.2018.09.007_bib24","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/nrmicro.2017.118","article-title":"The evolution of seasonal influenza viruses","volume":"16","author":"Petrova","year":"2018","journal-title":"Nat. Rev. Microbiol."},{"issue":"5","key":"10.1016\/j.virol.2018.09.007_bib25","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.4049\/jimmunol.0803467","article-title":"Vaccinia virus-based multivalent H5N1 avian influenza vaccines adjuvanted with IL-15 confer sterile cross-clade protection in mice","volume":"182","author":"Poon","year":"2009","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.virol.2018.09.007_bib26","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1093\/cid\/cir753","article-title":"Boosting heterosubtypic neutralization antibodies in recipients of 2009 pandemic H1N1 influenza vaccine","volume":"54","author":"Qiu","year":"2011","journal-title":"Clin. Infect. Dis."},{"issue":"1","key":"10.1016\/j.virol.2018.09.007_bib27","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1093\/infdis\/jiu662","article-title":"Seasonal influenza can poise hosts for CD4 T-cell immunity to H7N9 avian influenza","volume":"212","author":"Richards","year":"2015","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.virol.2018.09.007_bib28","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2016.00253","article-title":"Partial Protection against Porcine influenza a Virus by a hemagglutinin-expressing Virus replicon Particle Vaccine in the absence of neutralizing antibodies","volume":"7","author":"Ricklin","year":"2016","journal-title":"Front. Immunol."},{"issue":"7","key":"10.1016\/j.virol.2018.09.007_bib29","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/j.vaccine.2017.11.065","article-title":"Conventional influenza vaccines influence the performance of a universal influenza vaccine in mice","volume":"36","author":"Rowell","year":"2018","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.virol.2018.09.007_bib30","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1084\/jem.184.4.1543","article-title":"Perforin and Fas killing by CD8+ T cells limits their cytokine synthesis and proliferation","volume":"184","author":"Sad","year":"1996","journal-title":"J. Exp. Med."},{"issue":"10","key":"10.1016\/j.virol.2018.09.007_bib31","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1038\/nm.3350","article-title":"Cellular immune correlates of protection against symptomatic pandemic influenza","volume":"19","author":"Saranya","year":"2013","journal-title":"Nat. Med."},{"key":"10.1016\/j.virol.2018.09.007_bib32","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/B978-1-4160-3611-1.50006-4","article-title":"Vaccine immunology","volume":"5","author":"Siegrist","year":"2008","journal-title":"Vaccines"},{"issue":"4","key":"10.1016\/j.virol.2018.09.007_bib33","doi-asserted-by":"crossref","first-page":"e1005578","DOI":"10.1371\/journal.ppat.1005578","article-title":"Broadly-reactive neutralizing and non-neutralizing antibodies directed against the H7 influenza virus hemagglutinin reveal divergent mechanisms of protection","volume":"12","author":"Tan","year":"2016","journal-title":"PLoS Pathog."},{"issue":"3","key":"10.1016\/j.virol.2018.09.007_bib34","first-page":"417","article-title":"Influenza nucleoprotein-specific cytotoxic T-cell clones are protective in vivo","volume":"58","author":"Taylor","year":"1986","journal-title":"Immunology"},{"issue":"12","key":"10.1016\/j.virol.2018.09.007_bib35","doi-asserted-by":"crossref","first-page":"e3942","DOI":"10.1371\/journal.pone.0003942","article-title":"Heterosubtypic neutralizing monoclonal antibodies cross-protective against H5N1 and H1N1 recovered from human IgM+ memory B cells","volume":"3","author":"Throsby","year":"2008","journal-title":"PLoS One"},{"issue":"15","key":"10.1016\/j.virol.2018.09.007_bib36","doi-asserted-by":"crossref","first-page":"5676","DOI":"10.1073\/pnas.1403684111","article-title":"IL-15 adjuvanted multivalent vaccinia-based universal influenza vaccine requires CD4+ T cells for heterosubtypic protection","volume":"111","author":"Valkenburg","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.virol.2018.09.007_bib37","doi-asserted-by":"crossref","first-page":"22666","DOI":"10.1038\/srep22666","article-title":"Stalking influenza by vaccination with pre-fusion headless HA mini-stem","volume":"6","author":"Valkenburg","year":"2016","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.virol.2018.09.007_bib38","doi-asserted-by":"crossref","first-page":"e02556","DOI":"10.1128\/mBio.02556-14","article-title":"Vaccination with adjuvanted recombinant neuraminidase induces broad heterologous, but not heterosubtypic, cross-protection against influenza virus infection in mice","volume":"6","author":"Wohlbold","year":"2015","journal-title":"MBio"},{"key":"10.1016\/j.virol.2018.09.007_bib39","first-page":"359","article-title":"Evolution and ecology of influenza A viruses","volume":"385","author":"Yoon","year":"2014","journal-title":"Curr. Top. Microbiol. Immunol."}],"container-title":["Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682218302782?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682218302782?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T00:46:43Z","timestamp":1758588403000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0042682218302782"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":39,"alternative-id":["S0042682218302782"],"URL":"https:\/\/doi.org\/10.1016\/j.virol.2018.09.007","relation":{},"ISSN":["0042-6822"],"issn-type":[{"value":"0042-6822","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Combined use of live-attenuated and inactivated influenza vaccines to enhance heterosubtypic protection","name":"articletitle","label":"Article Title"},{"value":"Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.virol.2018.09.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc.","name":"copyright","label":"Copyright"}]}}